DIVERSIFY WEALTH MANAGEMENT, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2030780
SANDY, UT
Position in VRTX
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$9,927,477
+$4,627,699 QoQ
Shares Held
22,232
+90.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0.013494062612450522.ToString("F0")%
Shared 0.ToString("F0")%
None 99.98650593738755.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Mar 31, 2026CallValue
$44,654
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIVERSIFY WEALTH MANAGEMENT, LLC holds $21,079,655 across 12 Biotechnology names. VRTX ranks #1 (47.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
22,232 | $9,927,477 | |
| 2 | ASND |
Ascendis Pharma A/S
|
10,675 | $2,441,692 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
31,504 | $2,036,103 | |
| 4 | ABVX |
Abivax S.A.
|
17,736 | $1,974,903 | |
| 5 | ARGX |
Argenx SE
|
1,884 | $1,375,791 | |
| 6 | DBVT |
DBV Technologies S.A.
|
63,672 | $1,330,108 | |
| 7 | GMAB |
Genmab A/S
|
46,564 | $1,249,312 | |
| 8 | INSM |
INSMED Inc
|
1,704 | $278,638 |
All Filings in VRTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,927,477 | 22,232 | Shares | Sole | 2026-05-01 | |
| 2026-03-31 | $44,654 | 100 | Call | Sole | 2026-05-01 | |
| 2025-12-31 | $5,299,778 | 11,690 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $4,783,490 | 12,214 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,782,257 | 12,988 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,338,837 | 11,012 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $3,935,587 | 9,773 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,742,189 | 3,746 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,380,849 | 2,946 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||